行业研究报告题录
制造业--医药制造业(2014年第26期)
(报告加工时间:2014-09-21 -- 2014-09-30)

行业资讯

境内分析报告

  • 新兴产业周刊——2014年第36期
    本刊以七大战略性新兴产业——高端装备制造、节能环保、新能源、新材料、新能源汽车、生物、新一代信息技术为研究重点,关注国家高层和各部委的动态,剖析国家和地方的新兴产业政策。本刊设有政策导读、领导讲话、七大战略性新兴产业本周国内外行业动态和重点企业新闻、投资专题四大板块,能够实时监测新兴产业和重点企业动态,把握新兴产业发展方向,研究发展重点,寻求发展机遇。
  • 医药汇编-第592期
    报告从政策环境、市场行情、厂商动态、科技研发、国际资讯、行业数据、分析评论等几个方面对医药行业进行了分析评论。
  • 医药竞争情报-第513期
    报告从医药行业事件分析、竞争环境、竞争对手、行业数据等几个方面进行了分析评论。
  • 中国生物技术报告(2014年9月23日)
    China has made breakthroughs in some priority areas, including genomics, bioinformatics, identification of genes related to major diseases, molecular biology and biochemistry, cell and developmental biology, neurobiology, systematics and coevolution of animals and plants.
  • 新兴产业周刊——2014年第35期
    本刊以七大战略性新兴产业——高端装备制造、节能环保、新能源、新材料、新能源汽车、生物、新一代信息技术为研究重点,关注国家高层和各部委的动态,剖析国家和地方的新兴产业政策。本刊设有政策导读、领导讲话、七大战略性新兴产业本周国内外行业动态和重点企业新闻、投资专题四大板块,能够实时监测新兴产业和重点企业动态,把握新兴产业发展方向,研究发展重点,寻求发展机遇。

境外分析报告

  • 全球动物疫苗市场报告(2014-2018年)
    This report covers the present scenario and the growth prospects of the Global Animal Vaccines market for the period 2013–2018.
  • 全球医疗信息系统市场报告(2014-2018年)
    A healthcare information system is an integrated system designed for capturing, storing, managing, and transmitting information related to the healthcare of individuals. It collects data from the Healthcare and other relevant sectors, analyzes these data, ensures their overall quality, relevance, and timeliness, and converts the data into information for health-related decision making.

外文技术报告

  • 腹膜透析概述
    It is estimated that there are over one million patients with end-stage renal disease (ESRD) treated with dialysis around the world. While the overwhelming majority of these patients are treated with extra-corporeal therapies in dialysis units (hemodialysis), over 10perform their dialysis treatments at home - virtually all these patients use peritoneal dialysis (PD). In at least two countries - Hong Kong and Thailand - end-stage renal disease patients are eligible for governmental financial support for dialysis services only if they begin treatment with PD. In PD, a naturally occurring membrane, the peritoneal membrane, is used as dialysis membrane and over the years, the therapy has developed such that it allows successful removal of sufficient amount of solutes and fluid required to sustain life even in individuals without any residual kidney function. PD involves the instillation of dialysate fluid through an indwelling abdominal catheter and allowing it to dwell for variable periods of time before exchanging it with fresh dialysate. Most patients require dialysis to be performed continuously - 24 hours a day, seven days a week. Recent studies from different parts of the world show that the 5- and 10-year mortality of patients treated either with in-center hemodialysis or peritoneal dialysis are remarkably similar. In this chapter, we present an overview of the development of the therapy, key components that allow the therapy to be performed in its current form, and the complications of the therapy.
  • 基于超声波的局部乳腺放射治疗
    In this report, we extend our previous work where we proposed 1D Analytic Minimization (1D AM) of a cost function to calculate robust elasticity images to 2D AM. We show that 2D AM is much faster than 1D AM, which is critically important in creating real- time elastography. In elasticity reconstruction using an inverse problem framework. We also propose a novel strain addition, 2D AM produces high quality strain images in 2D which can be used for calculation technique using Kalman filters, which generates smooth strain images without blurring the images and removing sharp boundaries. We show using simulation, phantom and clinical trials that the 2D AM generates high quality strain images in real-time. This work is in published in 2 IEEE TMI articles (23 pages total), and in 5 conference proceeding papers (each paper 8 to 9 pages, 42 pages total). The papers are well received, resulting in more than 55 citations to date according to Google Scholar.
  • 自然杀伤T细胞对于乳腺癌的免疫原性化疗作用
    During this second year of investigation, we have confirmed the important role of gamma delta T cells in the efficacy of immunogenic chemotherapy using anthracyclines. In the meantime, the NKT cells seem to be dispensable for this effect at least in this particular situation. Moreover, we have also identified a population of gamma delta T cells with a unique phenotype never described before (CD3bright). Interestingly, this population has a clear intrinsic ability to produce IL-17 compared to any other gamma delta T cells and are represented at a high frequency in breast cancer tumor environment. We have highlighted several key homeostatic factors on this population and identified their precise phenotype. Of interest a human gamma delta T cell population display a similar phenotype (CD3bright) with gamma delta T17-like cell hallmarks. Our future efforts will focus on this population and their putative role in immunogenic chemotherapy for breast cancer.

如果没有您需要的报告,您可以到行业研究报告数据库(http://hybg.hbsts.org.cn )查找或定制

如果您在使用中有任何问题,请及时反馈给我们。